Immix Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immix Biopharma generated cash of -$11,371,438, which is less than the previous year. Cash used in financing activities reached the amount of $15,463,512 last year. Net change in cash is therefore $4,073,077.
Cash Flow
| 2019 | -790.03K | -7.30K | 1.05M |
|---|---|---|---|
| 2020 | -404.69K | 0 | 0 |
| 2021 | -1.58M | -802 | 18.84M |
| 2022 | -7.40M | 0 | 3.23M |
| 2023 | -11.37M | -52.08K | 15.46M |
IMMX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 13.43M | 17.64M | 391.08K | 734.01K | 462.32K |
Operating activities | |||||
Net income | -15.59M | -8.22M | -24.38M | -1.14M | -972.81K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 5.46K | 2.13K | 2.46K | 2.32K | 1.08K |
Stock-based compensation expense | 2.56M | 624.06K | 218.98K | 0 | 0 |
| Deferred income tax benefit | 2.56M | 624.06K | 218.98K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -236.38K | 97.66K | 58.49K | -36.29K |
Inventories | 0 | 236.38K | -97.66K | -58.49K | 36.29K |
Accounts payable | 2.43M | 1.13M | -106.06K | -3.83K | 122.95K |
Cash generated by operating activities | -11.37M | -7.40M | -1.58M | -404.69K | -790.03K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -52.08K | 0 | -802 | 0 | -7.30K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -52.08K | 0 | -802 | 0 | -7.30K |
Financing activities | |||||
Common Stock Issued | 15.69M | 0 | 18.64M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -99.96K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -200K | 0 | 1.05M |
Cash used in financing activities | 15.46M | 3.23M | 18.84M | 0 | 1.05M |
Net Change In Cash | 4.07M | -4.20M | 17.25M | -342.92K | 271.68K |
Cash at end of period | 17.50M | 13.43M | 17.64M | 391.08K | 734.01K |
| Data source | Data source | Data source |